Abstract:figure legend This study investigated the effects of fetal hyperglucagonaemia on insulin secretion and pancreatic development in late‐gestation sheep. Fetal sheep were infused with low (GCG‐5) or high (GCG‐50) doses of glucagon, resulting in reduced plasma insulin and amino acid concentrations, with no changes in plasma glucose. Chronic exposure to impaired glucose‐stimulated insulin secretion (GCG‐50 only), decreased β‐ and α‐cell proliferation, reduced pancreatic mass and lowered islet area (GCG‐50 only). These findings demonstrate that elevated fetal glucagon negatively impacts fetal pancreatic development and insulin secretion, potentially increasing the risk of metabolic diseases later in life. Fetal glucagon concentrations are elevated in the presence of a compromised intrauterine environment, as in cases of placental insufficiency and perinatal acidaemia. Our objective was to investigate the impact of late gestation fetal hyperglucagonaemia on in vivo insulin secretion and pancreatic islet structure. Chronically catheterized late gestation fetal sheep received an intravenous infusion of glucagon at low (5 ng/kg/min; GCG‐5) or high (50 ng/kg/min; GCG‐50) concentrations or a vehicle control (CON) for 8–10 days. Glucose‐stimulated fetal insulin secretion (GSIS) was measured following 3 h (acute response) and 8–10 days (chronic response) of experimental infusions. Insulin, glucose and amino acid concentrations were measured longitudinally. The pancreas was collected at the study end for histology and gene expression analysis. Acute exposure (3 h) to GCG‐50 induced a 3‐fold increase in basal insulin concentrations with greater GSIS. Meanwhile, chronic exposure to both GCG‐5 and GCG‐50 decreased basal insulin concentrations 2‐fold by day 8–10. Chronic GCG‐50 also blunted GSIS at the study end. Fetal amino acid concentrations were decreased within 24 h of GCG‐5 and GCG‐50, while there were no differences in fetal glucose. Histologically, GCG‐5 and GCG‐50 had lower β‐ and α‐cell proliferation, as well as lower α‐cell mass and pancreas weight, while GCG‐50 had lower islet area. This study demonstrates that chronic glucagon elevation in late gestation fetuses impairs β‐cell proliferation and insulin secretion, which has the potential to contribute to later‐life diabetes risk. We speculate that the action of glucagon in lower circulating fetal amino acid concentrations may have a suppressive effect on insulin secretion. Key points We have previously demonstrated in a chronically catheterized fetal sheep model that experimentally elevated glucagon in the fetus impairs placental function, reduces fetal protein accretion and lowers fetal weight. In the present study, we further characterized the effects of elevated fetal glucagon on fetal physiology with a focus on pancreatic development and β‐cell function. We show that experimentally elevated fetal glucagon results in lower β‐ and α‐cell proliferation, as well as decreased insulin secretion after 8−10 days of glucagon infusion. These results have important implications for β‐cell reserve and later‐life predisposition to diabetes.

Alloxan-induced diabetes mellitus in pregnant sheep and chronic fetal catheterization

Chronic pulsatile hyperglycemia reduces insulin secretion and increases accumulation of reactive oxygen species in fetal sheep islets.

Hypoxaemia-Induced Catecholamine Secretion From Adrenal Chromaffin Cells Inhibits Glucose-Stimulated Hyperinsulinaemia In Fetal Sheep

Evaluation of three therapeutic alternatives for the early treatment of ovine pregnancy toxaemia

Effects of maternal periconceptional undernutrition in sheep on offspring glucose-insulin axis function into adulthood

Islet Adaptations in Fetal Sheep Persist Following Chronic Exposure to High Norepinephrine.

An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep

The effect of a chronic maternal cortisol infusion on the late-gestation fetal sheep

Chronic late gestation fetal hyperglucagonaemia results in lower insulin secretion, pancreatic mass, islet area and beta‐ and α‐cell proliferation

Alteration of Fetal Blood-Gas, pH and Biochemical Parameters after Placental Occlusion in Ewe

Effects of infusions of ACTH in the chronically catheterized pregnant ewe and her fetus

204 Awardee Talk: Poor Maternal Nutrition Impacts Metabolic Factors and Glucose Tolerance in Sheep Offspring

Adrenal Demedullation and Oxygen Supplementation Independently Increase Glucose-Stimulated Insulin Concentrations in Fetal Sheep with Intrauterine Growth Restriction.

Timed interruption of insulin therapy in diabetic BB/E rat pregnancy: effect on maternal metabolism and fetal outcome

Intrauterine Hyperglycemia Induces Hepatic Steatosis in Mouse Offspring Via Altered Lipid Gene Expressions

Absence of Metformin in Fetal Circulation Following Maternal Administration in Late Gestation Pregnant Sheep

Inhibition of chemokine (C-X-C motif) receptor four (CXCR4) at the fetal-maternal interface during early gestation in sheep: alterations in expression of chemokines, angiogenic factors and their receptors

Uising WinBUGS to fit nonlinear mixed models with an application to pharmacokinetic modelling of insulin response to glucose challenge in sheep exposed antenatally to glucocorticoids

Enhanced Insulin Secretion Responsiveness and Islet Adrenergic Desensitization after Chronic Norepinephrine Suppression is Discontinued in Fetal Sheep.

Diabetes in the Cohen Rat Intensifies the Fetal Pancreatic Damage Induced by the Diabetogenic High Sucrose Low Copper Diet

Oxidative Damage and Exocrine Dysfunction of Ovine Fetal Pancreas Are Induced by Maternal Nutritional Restriction